ArticleLa Radiologia medica2026
Prognostic value of body composition analysis in cancer patients treated with immunotherapy: a systematic evaluation of TotalSegmentator-based biomarkers.
Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeBody composition parameters offer objective, imaging-derived prognostic biomarkers, valuable in the context of oncological diseases. This study evaluated the predictive value for overall survival of body composition parameters automatically derived via TotalSegmentator in cancer patients undergoing immunotherapy. MATERIALS AND
methodsWe retrospectively included pretreatment CT of chest, abdomen, and pelvis (CT CAP) of patients with advanced non-small cell lung cancer or melanoma. Following TotalSegmentator v2.8.0 segmentation, skeletal muscle (SM), visceral adipose tissue (VAT), subcutaneous adipose tissue (SAT), intramuscular adipose tissue (IMAT) volumes from T1 to the sacrum and areas at the T4, L3 levels were quantified, alongside soft tissue densities. Pearson correlations, height-normalized indices, and tissue-to-bone ratios were calculated. Survival was analyzed using Kaplan-Meier curves, log-rank tests, and multivariable age/sex-adjusted Cox regression and the c-index.
resultsOf the 357 patients, the one-year and five-year mortality rates were 52% (95% CI 47-58%) and 84% (95% CI 80-88%), respectively. Body composition parameters at the L3 level and in CAP volume were strongly correlated (r = 0.87-0.98). Differences between short and long survival groups were significant for all CAP volume-based body composition biomarkers, while area-based IMAT and VAT height-squared values were not discriminative at the L3 and T4 levels, respectively (p = 0.068 and p = 0.169). Cox models with muscle-to-bone ratio and SM index yielded similar c-indexes (0.616 and 0.618). The best c-index was achieved integrating quantity and density biomarkers of all tissues (0.621).
conclusionTotalSegmentator v2.8.0-derived CT CAP volume-based parameters were associated with immunotherapy overall survival, enabling routine volumetric prognostication to optimize treatment.
Indexed as
Identifiers
42613494What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.